We are live on ! Find out more
ACM

Ashford Capital Management Portfolio holdings

AUM $809M
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+14.91%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.15%
5 Year Est. Return
+109.93%
10 Year Est. Return
+1,281.06%
AUM
$746M
AUM Growth
+$67.1M
Cap. Flow
-$5.67M
Cap. Flow %
-0.76%
Top 10 Hldgs %
36.16%
Holding
95
New
4
Increased
32
Reduced
37
Closed
2

Top Buys

Rank Stock Value
1
SKWD icon
Skyward Specialty Insurance
SKWD
+$12.3M
2
CLBT icon
Cellebrite
CLBT
+$11.6M
3
PGNY icon
Progyny
PGNY
+$9.89M
4
CYBR
CyberArk
CYBR
+$9.73M
5
ODD icon
ODDITY Tech
ODD
+$8.93M

Sector Composition

Rank Sector Weight
1 Technology 23.06%
2 Healthcare 18.58%
3 Financials 17.18%
4 Industrials 12.27%
5 Communication Services 5.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ODD icon
1
ODDITY Tech
ODD
$708M
$33.5M 4.49%
720,260
+264,021
+58% +$8.93M
AXON
2
Axon Enterprise
AXON
$40.5B
$30.7M 4.11%
118,720
-12,845
-10% -$2.89M
CPRT icon
3
Copart
CPRT
$25.9B
$30.1M 4.04%
614,884
-126,950
-17% -$6M
CSGP icon
4
CoStar Group
CSGP
$11.3B
$28.4M 3.81%
325,176
-25,150
-7% -$2.04M
HQY icon
5
HealthEquity
HQY
$7.91B
$27.1M 3.63%
408,682
+4,403
+1% +$305K
SKWD icon
6
Skyward Specialty Insurance
SKWD
$2.45B
$25.6M 3.43%
755,100
+400,300
+113% +$12.3M
SNEX icon
7
StoneX
SNEX
$8.83B
$24.3M 3.26%
1,113,085
-181,548
-14% -$3.45M
SUPN icon
8
Supernus Pharmaceuticals
SUPN
$2.68B
$23.9M 3.2%
826,488
-90,259
-10% -$2.39M
INCY icon
9
Incyte
INCY
$23.5B
$23.4M 3.14%
372,769
-76,075
-17% -$4.3M
MKTX icon
10
MarketAxess Holdings
MKTX
$4.15B
$22.8M 3.05%
77,859
-10,963
-12% -$2.65M
QTRX icon
11
Quanterix
QTRX
$173M
$22.7M 3.05%
831,885
+33,860
+4% +$797K
TYL icon
12
Tyler Technologies
TYL
$12.2B
$22.7M 3.04%
54,241
+1,511
+3% +$604K
RDVT icon
13
Red Violet
RDVT
$859M
$22.1M 2.96%
1,107,240
-123,360
-10% -$2.46M
VTI icon
14
Vanguard Total Stock Market ETF
VTI
$654B
$21.9M 2.93%
92,286
+2,836
+3% +$627K
CYBR
15
DELISTED
CyberArk
CYBR
$21.3M 2.86%
97,410
+52,490
+117% +$9.73M
DV icon
16
DoubleVerify
DV
$1.62B
$20.9M 2.8%
567,840
+9,470
+2% +$295K
CVCO icon
17
Cavco Industries
CVCO
$4.39B
$20.1M 2.69%
57,870
-4,920
-8% -$1.4M
VSAT icon
18
Viasat
VSAT
$9.79B
$19.7M 2.64%
706,180
-186,365
-21% -$3.89M
KNSL icon
19
Kinsale Capital Group
KNSL
$7.95B
$16.3M 2.18%
48,525
+4,620
+11% +$1.71M
GSHD icon
20
Goosehead Insurance
GSHD
$1.39B
$15.3M 2.06%
202,435
-81,095
-29% -$5.86M
NVEE
21
DELISTED
NV5 Global
NVEE
$15M 2.01%
539,920
-112,416
-17% -$2.86M
TTD icon
22
Trade Desk
TTD
$8.13B
$14.7M 1.97%
204,526
+29,440
+17% +$2.16M
TWLO icon
23
Twilio
TWLO
$29.1B
$13.4M 1.8%
177,121
-29,476
-14% -$1.84M
CLBT icon
24
Cellebrite
CLBT
$3.55B
$12.9M 1.73%
+1,491,100
New +$11.6M
FNV icon
25
Franco-Nevada
FNV
$41.4B
$12.6M 1.69%
113,862
+14,405
+14% +$1.75M

Similar funds

Ashford Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Ashford Capital Management held 95 positions worth $746M, up 9.9% from $679M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ashford Capital Management's Q4 2023 filing shows 4 new, 32 increased, 37 reduced and 2 closed positions. Its largest new stake was Cellebrite: 1,491,100 shares worth $12.9M. The largest sale was Harmony Biosciences, an estimated $14.2M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Ashford Capital Management's largest Q4 2023 buy was Cellebrite: 1,491,100 shares worth $12.9M.
  • Ashford Capital Management added most to Skyward Specialty Insurance in Q4 2023, an estimated $12.3M increase.
  • Ashford Capital Management's biggest Q4 2023 reduction was Vicor, cutting an estimated $13.7M.
  • Ashford Capital Management fully exited Harmony Biosciences in Q4 2023, selling an estimated $14.2M.
  • Ashford Capital Management's ten largest holdings make up 36% of its $746M portfolio in Q4 2023.
  • Ashford Capital Management opened 4 new positions and closed 2 in Q4 2023.
  • Ashford Capital Management's portfolio value rose 9.9% quarter-over-quarter to $746M.

Based on Ashford Capital Management's 13F filing for Q4 2023, filed 15 Feb 2024.